August 4, 2022
PA-21-071 - Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)
NOT-OD-21-134 - Notice of Special Interest (NOSI): Research Supplements to Promote Re-Entry and Re-integration into Health-Related Research Careers (Admin Supp - Clinical Trial Not Allowed)
NOT-AR-19-011 - Notice of Change to NIAMS Acceptance of Diversity and Re-Entry Supplement Applications
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
This Notice updates and replaces NOT-AR-19-011. Effective immediately, NIAMS accepts and reviews applications on a continuous basis between October 1 and April 15 (previously May 31). This Notice pertains to applications submitted in response to PA-21-071, "Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)" and NOT-OD-21-134 Notice of Special Interest (NOSI): Research Supplements to Promote Re-Entry and Re-integration into Health-Related Research Careers (Admin Supp - Clinical Trial Not Allowed).
Applications received outside of these dates will be returned, but could be resubmitted during the next receipt period, if appropriate. Incomplete applications will be withdrawn and not reviewed. Please be mindful that the process takes approximately 3 months from receipt to award. For additional information please see https://www.niams.nih.gov/diversity-supplement-faqs.
NIAMS Diversity Supplement Program
and Human Services (HHS)
